Announced Mon, 24 Aug · 17:46 IST
New promoter group takes over Parmax Pharma with 30.80 percent stake acquisition
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹131.15
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
———————+1.0——————
Up moveDown movePending
AI summary
Parmax Pharma sees a change of control. Dhiren Shah, Sunil Shah and 10 persons acting in concert acquired 11,52,450 shares equal to 30.80 percent of equity from the Gopani family via a Share Purchase Agreement dated June 8, 2026 followed by an Open Offer under SEBI Takeover Rules. New acquirers will be classified as Promoters, others as Promoter Group members under SEBI LODR Regulation 31A, while the Gopani family moves to Public category.
Likely market impact
Major ownership change brings new management at Parmax Pharma. Watch for board and strategy updates that could reshape the business direction.